Hepatitis C

Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir

Evaluation of Patients With Liver Disease

Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

Reaching mEthadone Users Attending Community pHarmacies With HCV

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

The HOPE Study: Characterizing Patients With Hepatitis B and C

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

Tele-Harm Reduction

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

Expanding the Pool in Orthotopic Heart Transplantation

HCV Tappt Adherence Study

Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Feasibility and Acceptability of HCV Treatment in Pregnancy

DBS TaT in Peer-assisted Telemedicine for Hepatitis C

Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Mobile Enhanced Prevention Support for People Leaving Jail